These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27354540)

  • 41. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
    Ma C; Wang Z; Xia R; Wei L; Zhang C; Zhang J; Zhao L; Wu H; Kang L; Yang S
    Biomed Pharmacother; 2021 May; 137():111344. PubMed ID: 33581653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA; Hwang YJ; Kim GR; Choe JS
    BMC Complement Altern Med; 2015 Oct; 15():347. PubMed ID: 26438035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
    Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
    Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease.
    Mesarwi OA; Moya EA; Zhen X; Gautane M; Zhao H; Wegbrans Giró P; Alshebli M; McCarley KE; Breen EC; Malhotra A
    Am J Respir Cell Mol Biol; 2021 Oct; 65(4):390-402. PubMed ID: 34003729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetal iron levels are regulated by maternal and fetal Hfe genotype and dietary iron.
    Balesaria S; Hanif R; Salama MF; Raja K; Bayele HK; McArdle H; Srai SK
    Haematologica; 2012 May; 97(5):661-9. PubMed ID: 22180422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
    Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
    Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
    Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.
    Tomatsu S; Orii KO; Fleming RE; Holden CC; Waheed A; Britton RS; Gutierrez MA; Velez-Castrillon S; Bacon BR; Sly WS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15788-93. PubMed ID: 14673107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.
    Manco M; Alisi A; Real JF; Equitani F; DeVito R; Valenti L; Nobili V
    J Hepatol; 2011 Sep; 55(3):647-653. PubMed ID: 21168460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.
    Constante M; Jiang W; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G229-37. PubMed ID: 16565419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hfe acts in hepatocytes to prevent hemochromatosis.
    Vujić Spasić M; Kiss J; Herrmann T; Galy B; Martinache S; Stolte J; Gröne HJ; Stremmel W; Hentze MW; Muckenthaler MU
    Cell Metab; 2008 Feb; 7(2):173-8. PubMed ID: 18249176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.